Announcements Trials
Browse Landscape

Phase

Phase 4 2Phase 3 2Phase NA 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Conditions

Shock, Septic 1Hypotension 1

Interventions

Cyclophosphamide 299Cisplatin 298Paclitaxel 257Radiotherapy 255Fluorouracil 234Carboplatin 234Docetaxel 230Doxorubicin 216Dexamethasone 166Gemcitabine 156Vincristine 147Etoposide 136Leucovorin 133Capecitabine 129Bevacizumab 129Prednisone 125Rituximab 118Methotrexate 118Cytarabine 110Filgrastim 99Trastuzumab 97Oxaliplatin 96pembrolizumab 83Pemetrexed 73Epirubicin 70Tamoxifen 69Drug Therapy 69Irinotecan 65Granulocyte Colony-Stimulating Factor 60Daunorubicin 58

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × Completed × Norepinephrine × Clear all
NCT01718613 2018-05-18

VANCS II

Instituto do Cancer do Estado de São Paulo

Phase 3 Completed
250 enrolled

Shock, Septic

NCT03215797 2018-01-23

Phenylephrine or Norepinephrine for a Better Hemodynamic Stability

The Second Affiliated Hospital of Dalian Medical University

Phase 3 Completed
40 enrolled

Hypotension

Data powered by HemOnc (CC BY 4.0) Colophon âš¡